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ABSTRACT 29 
The present study investigates the antibacterial activity of zebra blenny (Salaria 30 
basilisca) protein hydrolysates obtained by fermentation with a proteolytic bacterium, 31 
Bacillus mojavensis A21. The hydrolysate exhibited nutritional as well as antibacterial 32 
properties. The fermentative zebra blenny protein hydrolysate (FZPH) was fractionated by 33 
size exclusion chromatography on a Sephadex G-25 into six major fractions (F1-F6). Fraction 34 
F2, which exhibited the highest antibacterial activity against several Gram-positive and Gram-35 
negative bacteria, was further fractionated by reversed-phase high performance liquid 36 
chromatography (RP-HPLC). The most active fractions named A and B which exhibited 37 
antibacterial activity, were analysed using nano ESI-LC-MS/MS to identify the sequences of 38 
the peptides. A total of 28 and 41 peptides, containing 8 to 31 amino acid residues, were 39 
identified in sub-fractions A and B, respectively. Further, identified peptides sharing 40 
sequences with previously identified peptides were reported. The results of this study suggest 41 
that FZPH are good source of natural antimicrobial peptides. Therefore, ZPH could be a 42 
beneficial ingredient for nutraceuticals. 43 
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1. Introduction 56 
The excessive and uncontrolled use of antibiotics in medicine, animal production, and 57 
preservation of food products has greatly contributed to the emergence of resistant pathogens 58 
to conventional antibiotics which frequently leads in treatment failure, severe outcomes and 59 
increasing expenditures. Thus, the discovery of new antimicrobial compounds has become a 60 
major challenge of researchers and pharmaceutical industries. Therefore, there is great interest 61 
in finding new and safe antibacterial compounds from natural sources.  62 
Antimicrobial peptides (AMPs) are positively charged, usually have less than 50 amino 63 
acids, of which nearly 50% are hydrophobic and they are generally amphipathic (Van’t Hof, 64 
et al., 2001). They serve as an ancient defense mechanism against pathogenic microorganisms 65 
that easily come in contact with the host through the environment [1].  66 
Antimicrobial peptides (AMPs) from marine organism hydrolysates are increasingly 67 
isolated and reported during the last few years. Ennaas et al. [2] have recently isolated four 68 
antibacterial peptides from Protamex hydrolysates of Atlantic mackerel (Scomber scombrus) 69 
by-products. Among them SIFIQRFTT peptide totally inhibited tested Gram-positive 70 
(Listeria innocua) and Gram-negative (Esherichia coli) bacterial strains, while the others 71 
exhibited partial inhibition. A decapeptide (GLSRFTALK) inhibiting Staphylococcus aureus 72 
was identified from anchovy cooking waste water by-products [3]. Similarly,  antibacterial 73 
peptides fractions isolated from proteolysed snow crab and Atlantic rock crab by-products 74 
were found to exhibit inhibitory activity against several Gram-positive and Gram-negative 75 
bacteria [4, 5]. Balakrishnan et al. [6] reported that fermented protein hydrolysates from 76 
delimed tannery fleshings exhibited antioxidant and antibacterial activities. 77 
Marine biofunctional peptides have been described to be obtained using three methods: 78 
solvent extraction, enzymatic hydrolysis and microbial fermentation [7]. Although several 79 
protein hydrolysates have been produced by from plant and animal sources using exogenous 80 
proteases, few studies have been conducted on the generation of antibacterial peptides using 81 
microbial fermentation [8]. 82 
In this study, the antibacterial activity of zebra blenny muscle protein hydrolysates 83 
obtained by fermentation with Bacillus mojavensis A21 have been investigated for the first 84 
time. The most active hydrolysate has been characterized and free amino acid composition 85 
together with nucleotides and total amino acids were determined. The identification of the 86 
sequences of generated peptides in most active RP-HPLC fractions was done using mass 87 
spectrometry in tandem. 88 
 89 
2. Materials and methods 90 
2.1.  Reagents 91 
Acetonitrile was of HPLC grade from Scharlau (Scharlab SL, Barcelona). All solutions 92 
were freshly prepared in bi-distilled water obtained from a Culligan system; the resistivity 93 
was approximately 18 MΩ*cm. Other chemicals and reagents used were of analytical grade 94 
(HCl, Ethanol, TFA…) 95 
2.2. Materials 96 
Zebra blenny (Salaria basilisca) was freshly purchased from the fish market of Sfax city, 97 
Tunisia. The sample was packed in polyethylene bags, placed in ice with a sample/ice ratio of 98 
approximately 1:3 (w/w) and transported to the laboratory within 30 min. Muscles were 99 
separated and then rinsed with cold distilled water to remove salts and other contaminants. 100 
 101 
2.3.  Zebra blenny meat flour (ZMF) preparation  102 
Raw muscles from zebra blenny (500 g) in 1000 ml bi-distilled water were cooked for 20 103 
min at 100°C. The bones were removed from cooked fish and fillets were collected and dried 104 
in an oven at 80 °C for 18 h. The dried fish preparation was minced to obtain fine powder.  105 
 106 
2.4. Production of fermented zebra blenny protein hydrolysate 107 
B. mojavensis A21 [9] was used to produce protein hydrolysate through fermentation of 108 
zebra blenny meat proteins. Inoculum was routinely grown in Luria-Bertani broth medium 109 
composed of 10 g/l peptone, 5 g/l yeast extract and 5 g/l NaCl [10]. For the production of 110 
protein hydrolysate, B. mojavensis was grown in medium containing powdered zebra blenny 111 
meat (30 g/l; pH 8.0) as only carbon and nitrogen sources. The media were autoclaved at 121 112 
°C for 20 min. Cultivations were conducted in 1000 ml Erlenmeyer flask containing 100 ml of 113 
culture medium. Incubations were carried out in a shaking incubator (Technico Ltd, Chennai, 114 
India) at 200 rpm for 4 h to 48 h at 37 °C in order to select the best degree of hydrolysis (DH) 115 
that allows maximum bioactivity. Cultures were then centrifuged at 8500×g for 30 min at 4 116 
°C. Resulted cell-free supernatents, were freeze dried using freeze dryer (Bioblock Scientific 117 
Christ ALPHA 1-2, IllKrich-Cedex, France). The freeze dried powders with a yield of about 118 
0.3 g of dried powder/g of zebra blenny meat flour were then evaluated for compositions and 119 
antibacterial activities. All experiments were carried out in triplicate. 120 
 121 
2.5.  Determination of the degree of hydrolysis (DH) 122 
DH was measured using o-phthaldialdehyde (OPA) following the method referred by 123 
Nielsen et al. [11]. An aliquot of the sample (400 μl), at a concentration of 1 mg/ml, was 124 
added to 3 ml of OPA solution and homogenized for 5 seconds. The mixture’s absorbance 125 
was measured after 2 min at 340 nm. The same volume of distilled water instead of FZPH 126 
sample was used as control. A serine standard was also prepared (0.1 mg/ml).  127 
The DH was expressed in percentage and calculated using the following formulas : 128 
 129 
 130 
 131 
 132 
 133 
 134 
where Abssample is the absorbance of FZPH, Absserine is the absorbance of serine standard, 135 
Abscontrol is the absorbance of control, w is the weight in grams of FZPH sample in 100 mL 136 
and P is the protein content (%) of FZPH. Constants values of the number of equivalent 137 
peptide bonds per gram of protein (htot), α and β were assumed to be 8.6 meq g-1, 1 and 0.4, 138 
respectively, since these are the recommended values for fish by Nielsen et al. [11].  139 
Each experiment was done in triplicate. 140 
 141 
2.6.  Chemical analysis 142 
The moisture and ash content were determined according to the AOAC standard methods 143 
930.15 and 942.05, respectively [12]. Total nitrogen content of FZPH and undigested protein 144 
substrates was determined using the Kjeldahl method according to the AOAC method number 145 
984.13 [12] and the equipment of BÛCHI Digestion Unit K-424, Switzerland. Crude protein 146 
was estimated by multiplying total nitrogen content by the factor of 6.25. Fat content was 147 
determined gravimetrically after Soxhlet extraction of dried samples with hexane for 2 h using 148 
Nahita Model 655, Navarra. All measurements were performed in triplicate. 149 
 150 
2.7. Amino acid composition of FZPH and fractions from Sephadex G-25 151 
100 h DH = 
htot 
 
× 
 Serine–NH2 - β 
h = 
α 
× Serine –NH2 = 
0.9516 × 0.1 × 10 
 W × P 
 Abssample - Abscontrol 
 Absserine - Abscontrol 
Amino acid composition was determined after samples hydrolysis with 6 N HCl at 152 
110°C for 24 h under nitrogen atmosphere. After removing the HCl, freed amino acids were 153 
derivatized using phenylisothiocyanate according to Bidlingmeyer et al (1984) and analyzed 154 
by reversed-phase high performance liquid chromatography (HPLC) in a 1200 Agilent liquid 155 
chromatograph (Agilent Tech., CA, USA). Amino acids were separated using a Waters Pico 156 
Tag column (3.9 x 300 mm, 5 µm) by following the method described in Aristoy and Toldrá 157 
[13]. Detection was at 254 nm, and amino acids were identified by their retention times 158 
compared to standards. The amount of amino acids was calculated, based on the peak area in 159 
comparison with that of amino acids standard. The amino acid content was expressed as their 160 
respective percentage of number of residues in the sample. All analyses were performed in 161 
duplicate. 162 
 163 
2.8. Free amino acid analysis 164 
ZMF and FZPH were deproteinized by adding 3 volumes ACN for 1h. After 165 
centrifugation at 12,000 rpm for 5 min, 300 µl of the supernatants were dried. The free amino 166 
acids were analyzed by RP-HPLC as previously described. 167 
 168 
2.9. Nucleotides content 169 
Nucleotides and derived compounds were analyzed in ZMF and FZPH by RP-HPLC 170 
and analysed with an 1100 Agilent liquid chromatograph equipped with a diode array detector 171 
using a C-18 Synergi MAX-RP 4 μm, 80A, 150×4.6 mm (Phenomenex, Torrance, CA, USA) 172 
column at 30 °C. The chromatographic separation was performed according to Hernández-173 
Cázares et al. (2011). The separated compounds were monitored  at a wavelength of 260 nm 174 
for ATP, AMP, UMP, GMP, uridin and NAD and 250 nm for IMP, inosine and hypoxanthine 175 
and identified by their respective retention times and spectrum between 200 and 350 nm. 176 
Quantification was performed by means of their respective calibration curves. 177 
 178 
2.10. Maldi-ToF mass spectrometry analysis 179 
The analysis was done in a 5800 MALDI-ToF/TOF instrument (AB Sciex) in positive 180 
reflectron mode (3000 shots every position) in a range from 150 to 2000 Da; the laser 181 
intensity was manually adjusted to maximize the S/N ratio. Plate model and acquisition 182 
method were calibrated by AB SCIEX calibration mixture (des-Arg1-Bradykinin at 1 fmol/μl; 183 
Angiotensin I at 2 fmol/μl; Glu1-Fibrinopeptide B at 1.3 fmol/μl; ACTH (1–17 clip) at 2 184 
fmol/μl; ACTH (18–39 clip) at 5 fmol/μl; and ACTH (7–38 clip) at 3 fmol/μl) in 13 positions. 185 
Dried hydrolysates were dissolved in 5% ACN containing 0.1% TFA, and 1 μl of every 186 
sample was directly spotted on 10 positions in the MALDI plate and allowed to dry. Once 187 
dried, 0.5 μl ofmatrix solution (5 mg/ml of α-Cyano-4-hydroxycinnamic acid (CHCA) in 188 
0.1% TFA–ACN/H2O (7:3, v/v)) was spotted. 189 
The analysis of data was done using mMass software (http://www.mmass.org/). 190 
 191 
2.11. Antibacterial activity 192 
Antibacterial activity assays were performed according to the method described by 193 
Berghe and Vlietinck [14]. Antibacterial activities were tested against 6 Gram-negative (E. 194 
coli, P. aeruginosa, K. pneumoniae, S. enterica, S. typhi, Enterobacter sp.) and 3 Gram-195 
positive (S.aureus, B. cereus, M. luteus) bacteria. Samples were dissolved in distilled water, 196 
and sterilized by filtration through a 0.22 µm Nylon membrane filter. A 200 µl culture 197 
suspension of the microorganism (106 colony-forming units (cfu)/ml of bacteria cells 198 
estimated by absorbance at 600 nm) were spread on Muller–Hinton agar. Then, bores (3 mm 199 
depth, 4 mm diameter) were made using a sterile borer and were loaded with 80 µl of 200 
samples. The Petri dishes were kept, first during 1 h at 4 °C, and then during 24 h at 37 °C. 201 
Antibacterial activity was evaluated by measuring the diameter of the growth inhibition zones 202 
in millimeters. 203 
 204 
2.12. Fractionation and characterisation of peptides 205 
2.12.1. Size-exclusion chromatography 206 
The freeze dried FZPH (1g) was suspended in 5 ml of bi-distilled water, and then was 207 
subjected to Sephadex G-25 gel filtration column (2.9 cm × 54 cm) fractions of 5 ml were 208 
collected at a flow rate of 30 ml/h and the absorbance was measeared at 280 nm.  209 
 210 
2.12.2. Reversed-phase high performance liquid chromatography 211 
The most active fractions was dissolved in distilled water, filtered through 0.22 µm 212 
filters and then injected into an Agilent 1100 HPLC system for separation in a Symmetry 213 
Prep™ C18 column (4.6×250 mm, 5μm) from Waters (Milford, MA, USA). Solvent A was 214 
0.1% TFA in bidistilled water and solvent B consisted of ACN / bidistilled water (60:40, v/v) 215 
containing 0.085% of TFA. The mobile phases were filtered through a 0.45 μm filter and 216 
degassed. The elution was 100% solvent A for 2 min, followed by a linear gradient to 40% of 217 
solvent B in 50 min and then taken to 100% of solvent B and maintaining for 10 min at a flow 218 
rate of 1 ml/min. The chromatogram was monitored at 214 nm and collected fractions (1 ml) 219 
were freeze-dried then assayed for antibacterial activity. 220 
 221 
2.12.3.  Identification of peptides using nESI-LC–MS/MS 222 
Peptide identification was done using a nano-liquid chromatography system (Eksigent 223 
of AB Sciex, CA) coupled to a quadrupole-time-of-flight (Q-ToF) system (TripleTOF® 224 
5600+, AB Sciex Instruments, Framingham, MA) equipped with a nano-electrospray 225 
ionization source (nano-ESI). Systems parameters were adjusted as previously published in 226 
Mora et al. [15]. 227 
Regarding the spectra analysis, the peak list generation and database search for the 228 
identification of the peptides were done using Mascot Distiller v2.4.2.0 software (Matrix 229 
Science, Inc., Boston, MA).   230 
The NCBInr protein database was used to identify the peptides with a significance 231 
threshold p < 0.05 and a FDR (False Discovery Rate) of 1.5%. The tolerance on the mass 232 
measurement was 100 ppm in MS mode and 0.3 Da in MS/MS ions.  233 
BIOPEP (http://www.uwm.edu.pl/biochemia/index.php/pl/biopep) databases were used 234 
in the search of similar sequences previously identified antibacterial activity. 235 
 236 
2.13. Statistical analyses 237 
Statistical analyses were performed with Stratgraphics ver. 5.1, professional edition 238 
(Manugistics Corp., USA) using ANOVA analysis. Differences were considered significant at 239 
p< 0.05. 240 
 241 
3. Results and discussion 242 
3.1.  Preparation of fermented zebra blenny protein hydrolysate  243 
In this study,  previous tests were done in order to select the DH that allow to obtain the 244 
most active protein hydrolysate. The antibacterial activity against E. coli was measured as a 245 
function of time. 246 
As shown in Table 1, the highest growth inhibition was obtained after 12 h of 247 
incubation, thereafter the inhibitory activity decreased and then disappeared. Results 248 
demonstrate that DH had a significant effect on bacteria growth inhibition activity, and that 249 
the highest activity was reached with a DH of 17.35 % (12 h of incubation).  250 
FZPH with a DH of 17.35 % was further tested against several Gram+ and Gram – 251 
bacteria (Table 2). No antibacterial activity was detected with the undigested zebra blenny 252 
muscle proteins (t = 0). FZPH was found to inhibit the growth of M. luteus, E. coli, K. 253 
pneumoniae, S. enterica and Enterobacter sp., and the highest antibaterial activity was 254 
detected against E. coli and K. pneumoniae. 255 
 256 
3.2. Chemical composition, free amino acids and nucleotides content 257 
The chemical composition of freeze dried ZPH was determined (Table 3) and compared to 258 
that of zebra blenny meat flour. The proximate composition of dried ZMF showed high 259 
protein content (84.16% of dry matter basis) (p<0.05) whereas protein content was about 80% 260 
in FZPH (p<0.05). The fat content level in the hydrolysate was 0.08%, which was 261 
significantly lower than ZMF (5.44%) (p< 0.05). FZPH had high ash content (11.54%). 262 
In Table 4, free amino acid compositions of ZMF and FZPH are expressed as 263 
percentage of residues. The results revealed a wealth of Glu, Ala, Val and Ile. An important 264 
amount of Taurine was detected (10.52 % in ZMF and 15.52% in FZPH). 265 
Nucleotides and derived compound of undigested muscle and FZPH were determined 266 
by HPLC and are shown in Table 5. Hypoxanthine is the major compound in the undigested 267 
and FZPH samples (7.62 and 9 μmol/g, respectively), whereas ADP, ATP, and uric acid were 268 
undetectable. AMP was not detected in FZPH; UMP and uridine were also not detected in 269 
ZMF. Regarding this, it is well known that after death, ATP is rapidly split into ADP and 270 
subsequently into AMP and IMP. IMP is then degraded to inosine and hypoxanthine which in 271 
turn can be oxidized to uric acid [16]. So, the accumulation of hypoxanthine in the fish 272 
muscle hydrolysate can reflect the enzymatic breakdown. Nucleotides and especially IMP and 273 
GMP, which are abundant in seafood, are responsible for theumami taste sensation [17]. The 274 
presence of these nucleotides in ZMF, contributes to the umami sensor. In fact, it has been 275 
noted that the combination of nucleotides and umami-related amino acids (aspartic and 276 
glutamic acids) would increase synergistically the umami response. 277 
 278 
3.3. Amino acid composition 279 
The amino acid compositions of FZPH and its fractions, obtained after fractionation by 280 
G25 gel filtration and expressed as percentage of residues, are reported in Table 6. The amino 281 
acid compositions of the different samples revealed that they are rich in Lys, Glu, Ala and 282 
Gly. The sum of these amino acids was between 36.13% for ZMF and 52.92% for FZPH-F6. 283 
The obtained percentages were higher than previously published results in salmon (20.37%) 284 
and cod (7.15%) protein hydrolysates [18]. Taurine, a sulfur-containing amino acid derived 285 
from methionine and cysteine, was detected in all samples. The FZPH-F4 had the highest 286 
taurine content (4.28%), whereas less taurine was found in ZMF (0.28%). Taurine contents 287 
were similar to those reported by Lassoued et al. [19] in thornback ray protein hydrolysates 288 
and by Silva et al. [20] in tilapia protein hydrolysates. Taurine may be a relevant amino acid 289 
for use as a nutritional supplement to protect against oxidative stress, neurodegenerative 290 
diseases or atherosclerosis [21]. 291 
 292 
3.4. RP-HPLC profiles of ZMF and FZPH 293 
RP-HPLC efficiently separates peptides generated in protein hydrolysates, and can give 294 
some indication about hydrophobic/hydrophilic peptide ratio [22]. Several researchers have 295 
employed this technique in studying protein hydrolysates from bovine β-lactoglobulin [23] 296 
and thornback ray (Raja clavata) muscle hydrolysates [19]. The RP-HPLC elution profiles of 297 
ZMF and FZPH are presented in Fig. 1. Several peaks are detectable by RP-HPLC confirming 298 
the hydrolysis of the muscle protein and the generation of several peptides in FZPH. The 299 
retention times of tyrosine and tryptophan (13.3 min and 26.03 min, respectively) were used 300 
to divide the chromatograms into three zones. Zone 1 consisted of peptides eluted before 301 
tyrosine (hydrophilic peptides). Zone 2 comprised of peptides eluted between tyrosine and 302 
tryptophan (low hydrophobic peptides), while zone 3 comprised of those eluted after 303 
tryptophan (high hydrophobic peptides). FZPH showed a higher a high content of 304 
hydrophobic peptides.  305 
 306 
3.5.  MALDI-ToF mass spectrometry analysis 307 
In this study, MALDI-ToF mass spectrometry was used to distribution of peptides 308 
generated during fermentative hydrolysis from 600 to 1800 Da. As shown in Fig. 2, there is an 309 
extensive distribution of peptides in FZPH in a wide range of molecular masses. In fact, 310 
whereas no peptides were detected in ZMF (Fig. 2A), FZPH was mainly constituted of low 311 
molecular weight peptides in the range of 600–1800 Da. Many studies reported the molecular 312 
weight distribution of protein hydrolysates using the MALDI-ToF technique [24, 25, 26]. 313 
 314 
3.6. Fractionation and identification of peptides sequences 315 
The hydrolysate FZPH, with a DH of 17.35% and produced by B. mojavensis A21 after 316 
12 h of fermentation, contained a complex mixture of active and inactive molecules having 317 
various sizes and different amino acid sequences. Potential peptides, which may exhibit high 318 
antibacterial activity, are present at low concentration. Therefore, FZPH was fractionated by 319 
size exclusion chromatography on a Sephadex G-25 column to isolate antibacterial peptides. 320 
As reported in Fig. 3, six separated peaks, from F1 to F6 were obtained. The yields of F1, F2, 321 
F3, F4, F5 and F6 fractions were 12.55%, 6.86%, 11.55%, 7.65%, 2% and 1.4%, respectively. 322 
The fractions associated with each peak were pooled, freeze-dried and evaluated for 323 
antibacterial activity. As reported in Table 7, except F5 and F6 which didn’t display any 324 
antibacterial activity against all the strains tested, F1, F2, F3 and F4 showed varying degrees 325 
of antibacterial activities against at least one bacterium. Indeed, F1 was found to inhibit only 326 
E. coli, while F2 inhibit five strains. However, none of the six fractions were found to inhibit 327 
S. aureus, B. cereus and S. typhi. Therefore, F2 which displayed the highest antibacterial 328 
activity was selected and then further fractionated by RP-HPLC. Fractions (1 ml) were 329 
automatically collected, freeze-dried and their antibacterial activities were tested. The RP-330 
HPLC profile of F2 fraction, reported in Fig. 4, revealed a very large number of peaks relating 331 
to the abundance of peptides generated. Antibacterial activity was only detected in fractions 332 
eluted from 3 to 6 min (named sub-fraction A) and at 47 min (named sub-fraction B). These 333 
two sub-fractions were selected for the identification. 334 
 335 
3.7. Identification of bioactive peptides  336 
Peptides from selected sub-fractions A and B were analysed by nESI-LC–MS/MS after 337 
RP-HPLC separation. A total of 28 peptide sequences were identified in sub-fraction A and 338 
41 peptide sequences were identified in sub-fraction B. The amino acid sequences of the 339 
identified peptides were characterized as well as their position in the parent protein. The 340 
observed (m/z), the experimental and the calculated molecular masses (Mr) are also shown in 341 
Table 8. All the identified peptides were between 8 and 31 amino acids length, which is in 342 
accord with the study of Brogden [27] reporting that the size of AMPs varies from 6 aas 343 
residues to more than 59. Identified peptides have a substantial portion of hydrophobic 344 
residues. The most hydrophobic peptides are GLPPYPYAG, ALPYDTPVPGY, 345 
LAGNEDVILPVPA, VIISAPSADAPMF and FAGDDAPRAVFPS in sub-fraction A, and 346 
AAVPSGASTGVHEALEL, WAAFPPDVAGNVDYKN and 347 
LTVKEDQVFPMNPPKFDKIEDMAM in sub-fraction B. Wieprecht et al. [28] reported that 348 
this hydrophobic character would let peptides enter the membrane, as the positive charge 349 
would initiate the peptide interact with the surface of the bacteria (negatively charged). AMPs 350 
can be further categorized based on their amino acids content and proportion, e.g., some have 351 
a high content of one or two aas such as proline [29], arginine [30] and/or glycine [31]. If we 352 
focused on identified peptides in sub-fraction A, we found that GLPPYPYAG has two 353 
residues of glycine and three proline, ETPGGTPLAPEPD has four residues of proline and 354 
two glycine, while AGCAGVGGAG has five residues of glycine. In sub-fraction B, three 355 
residues of glycine were found in ISERLEEAGGATAA and four residues of arginine in 356 
GYPDKIIIGMD. This high content of P, R and/or G could be attribuated to the antimicrobial 357 
activity. 358 
By using Biopep databases, several potential antibacterial or antimicrobial peptides 359 
were detected in sub-fractions A and B (Table 9). 360 
In sub-fraction A, P1 (GLPPYPYAG) contain GLP at the N-terminal, which is also 361 
present at the N-terminal of GLPQE, an AMP derived from α S1-casein (10-14) [32]. Besides 362 
of its potential antibacterial action, P1 could probably be hypotensive. Indeed, GLP, derived 363 
from Alaska pollak skin, was found to exerce ACE-inhibitory activity [33]. Thus, this peptide 364 
could be probably an antimicrobial and hypotensive. Further, GIL tripeptide found at the C-365 
terminal sequence of P2 peptide was also present at the C-terminal sequence of temporin A, 366 
an antimicrobial peptide [34]. 367 
Comparaison revealed also the presence within the identified of peptides of tripeptides 368 
or tetrapeptides present in previously identified antibacterial or antimicrobial peptides (Table 369 
9). 370 
In sub-fraction B, 13 peptides were found to share some homology with previously 371 
identified antibacterial peptides (Table 9b). For example, peptide P6 contain IAK at the C-372 
terminal, which is also found at the C-ter of antibacterial and ACE inhibitor peptide 373 
FSDKIAK derived from bovine k-casein [35, 36]. In another study, Gomez-Ruiz et al [37] 374 
reported that the tripeptide IAK obtained from ovin milk protein exhibited a high ACE-375 
inhibitory activity. Similarly, QAA triprptide found at the C-ter op P16 peptide was also 376 
found at the C-ter of Hadrurin, an antimicrobial peptide from the venom of the scorpion 377 
Hadrurus oztecus [38]. This tripeptide could be implicated in the peptide action. 378 
In addition to peptides sharing some homology sequences with previously identified 379 
antibacterial peptides, potential ACE-inhibitor, DPP IV inhibitor and antioxidant peptides 380 
were also reported in Table 9. 381 
4. Conclusion 382 
In the present study, ZPH obtained by fermentation was found to possess antibacterial 383 
activity. The hydrolysate was fractionated by reversed-phase high performance liquid 384 
chromatography (RP-HPLC) and sequences were identified using nESI-LC–MS/MS. Many 385 
peptides were separated and the amino acid sequences were determined. 386 
Therefore, this research provided a scientific basis for the generation of antibacterial 387 
peptides from zebra blenny protein hydrolysates that could be utilized in nutraceutical. 388 
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Table 1 672 
Comparison of antibacterial activity of fermented zebra blenny protein hydrolysate, elabored 673 
using B. mojavensis, as function of time fermentation. The conditions of fermentation were 674 
100 ml of reation volume, [substrate] 30 g/l, pH 8.0, temperature 37°C, agitation 200 rpm. 675 
The indicator bacterium used was E. coli.  676 
  677 
Time 
fermentation 
(h) 
IZD (mm) 
0 − 
4 − 
6 − 
8 14 ± 1 
12 20 ± 1 
16 16 ± 1 
20 14 ± 1 
24 10 ± 1 
28 − 
32 − 
48 − 
 678 
The concentration of protein hydrolysate was 20 mg/ml. 679 
IZD: Inhibition Zone Diameter 680 
Values are given as mean±SD from triplicate determinations (n=3). 681 
«−» No inhibition or no effect. 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
 698 
 699 
 700 
 701 
 702 
Table 2 703 
Antibaterial activity of fermented zebra blenny protein hydrolysate produced after 12 h of 704 
fermentation, against various indicator organisms. 705 
 706 
Indicator organism ZMF FZPH 
Gram (+)    
S.aureus  − − 
B. cereus  − − 
M. luteus  − + 
Gram (-)    
E. coli  − +++ 
P. aeruginosa  − − 
K. pneumoniae  − ++ 
S. enterica  − + 
S. typhi  − − 
Enterobacter sp.  − + 
 707 
Zone inhibition: +++: >1.5 cm; ++: 1.0-1.5 cm, +: <1.0 cm, and -: No activity. 708 
 709 
 710 
 711 
 712 
 713 
 714 
 715 
 716 
 717 
 718 
 719 
 720 
 721 
 722 
 723 
 724 
Table 3 725 
Chemical constituents of undigested zebra blenny protein and its hydrolysate. 726 
 727 
 728 
 729 
 730 
 731 
 732 
 733 
 734 
Values are given as mean ± SD from triplicate determinations (n= 3). 735 
ZMF : zebra meat flour. 736 
FZPH : zebra blenny protein hydrolysate fermented using B. mojavensis A21 during 12h. 737 
a,b,c Different letters in the same line indicate significant differences (p < 0.05). 738 
 739 
 740 
 741 
 742 
 743 
 744 
 745 
 746 
 747 
 748 
 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
 757 
 758 
 759 
 760 
Composition (%) ZMF FZPH 
Protein 84.16 ± 0.41a 80.00 ± 0.25b    
Fat 5.44 ± 0.30a 0.08 ± 0.01b 
Moisture 8.67 ± 0.06b  9.64 ± 0.44a     
Ash   9.68 ± 0.32b 11.54 ± 0.21a  
Table 4 761 
Free amino acid composition of zebra blenny meat flour and its hydrolysates. 762 
 763 
 764 
 765 
 766 
 767 
 768 
 769 
 770 
 771 
 772 
 773 
 774 
 775 
 776 
Values are given as mean ± SD from duplicate determinations (n= 2). 777 
a,b Different letters in the same line indicate significant differences (p < 0.05). 778 
1 Asx = Asp + Asn; Glx= Glu + Gln. 779 
2 Essential amino acids. 780 
nd: not detected. 781 
 782 
 783 
 784 
 785 
 786 
 787 
 788 
 789 
 790 
 791 
 792 
 
Number of residues/100 
ZMF FZPH 
Aspartic acid (Asx)1 2.91 ± 0.37a 2.07 ± 0.27b 
Glutamic acid (Glx)1 7.97 ± 0.29b 13.29 ± 0.14a 
Serine (Ser) 5.36 ± 0.08a 1.40 ± 0.09b 
Histidine (His)2 nd nd 
Glycine (Gly) 3.97 ± 0.35a 4.00 ± 0.24a 
Threonine (Thr)2 6.88 ± 0.11a 3.84 ± 0.34b 
Alanine (Ala) 15.25 ± 0.22a 9.60 ± 0.46b  
Arginine (Arg) 7.05 ± 0.04b 7.72 ± 0.07a 
Taurine (Tau) 10.52 ±0.38b 15.52 ± 0.28a 
Tyrosine (Tyr) 8.06 ± 0.41a 4.47 ± 0.44b 
Valine (Val)2 5.20 ± 0.24b 14.41 ± 0.07a 
Methionine (Met)2 nd nd 
Phenylalanine (Phe)2 4.02 ± 0.27a 1.80 ± 0.33b 
 Isoleucine (Ile)2 2.97 ± 0.20b 11.81 ± 0.24a 
Leucine (Leu)2 6.19 ± 0.37a 5.91 ± 0.25b 
Lysine (Lys)2 2.55 ± 0.32a 1.78 ± 0.12b 
Hydroxyproline (Hyp) 2.70 ± 0.10 nd 
Proline (Pro) 8.40 ± 0.37a 2.36 ± 0.17b 
Total 100 100 
Table 5 793 
Nucleotides composition of zebra blenny meat flour and zebra blenny protein hydrolysate. 794 
 795 
 796 
 797 
 798 
 799 
 800 
 801 
 802 
 803 
Values are given as mean ± SD from duplicate determinations (n= 2). 804 
a,b Different letters in the same line indicate significant differences (p < 0.05). 805 
nd: not detected. 806 
 807 
 808 
 809 
 810 
 811 
 812 
 813 
 814 
 815 
 816 
 817 
 818 
 819 
 820 
 821 
 822 
 823 
 824 
 
µmole/g 
ZMF FZPH 
ATP nd Nd 
AMP   1.43 ± 0.57   Nd 
ADP nd Nd 
IMP  0.92 ± 0.14a   1.12 ± 0.25a  
Inosine 0.56 ± 0.08b 0.74 ± 0.21a 
Hypoxanthine  7.62 ± 0.37b  9.00 ± 0.15a  
Uridine  nd   1.30 ± 0.28  
Uric acid nd Nd 
UMP nd 0.63 ± 0.23 
GMP nd 0.70 ± 0.15 
Table 6 825 
Amino acid composition of zebra blenny meat flour, its hydrolysate and its G25 fractions. 826 
 827 
 
Number of residues/100 residues 
ZMF FZPH F1 F2 F3 F4 F5 F6 
Aspartic acid (Asx)1 7.00 ± 0.02e 8.04 ± 0.05c,d 9.20 ± 0.01a 8.66 ± 0.09 b 8.80 ± 0.05b 8.09 ± 0.08c,d 8.22 ± 0.16c 7.93 ± 0.05d 
Glutamic acid (Glx)1 7.60 ± 0.13 f 15.07 ± 0.02c 16.75 ± 0.10a 16.75 ± 0.06 a 16.51 ± 0.34b 14.68 ± 0.03d 13.42 ± 0.24e 13.41 ± 0.18e 
Serine (Ser) 4.02 ± 0.10 a 3.70 ± 0.07b,c 3.93 ± 0.02 a 3.81 ± 0.02 b 3.65 ± 0.05 c 3.62 ± 0.12 c 3.73 ± 0.09b,c 3.60 ± 0.08c 
Histidine (His)2 2.94 ± 0.02 a 1.05 ± 0.17 d nd nd nd 1.29 ± 0.29 c 1.09 ± 0.19 d 1.39 ± 0.22 b 
Glycine (Gly) 7.12 ± 0.02 f 10.10 ± 0.04d 12.22 ± 0.00 c 10.04 ± 0.01d 8.21 ± 0.05 e 10.19 ± 0.06d 16.84 ± 0.07b 20.78 ± 0.03a 
Threonine (Thr)2 4.38 ± 0.02 b 3.00 ± 0.08 d 5.51 ± 0.04 a 5.60 ± 0.05 a 4.43 ± 0.05 b 3.43 ± 0.15 c 3.33 ± 0.09 c 3.08 ± 0.12 d 
Alanine (Ala) 8.04 ± 0.02 c 9.94 ± 0.17 a 6.46 ± 0.07 e 6.15 ± 0.05 e 6.46 ± 0.14 e 8.57 ± 0.30 b 7.40 ± 0.23 d 7.60 ± 0.22 d 
Arginine (Arg) 7.09 ± 0.03 d 7.84 ± 0.08 c 9.13 ± 0.04 b 9.74 ± 0.06 a 9.92 ± 0.04 a 8.02 ± 0.14 c 5.92 ± 0.07 e 5.17 ± 0.11 f 
Taurine (Tau) 0.28 ± 0.02 e 2.13 ± 0.22 c 0.53 ± 0.02 e 1.37 ± 0.09 d 1.89 ± 0.23 c 4.28 ± 0.39 a 4.10 ± 0.20 a 3.35 ± 0.27 b 
Tyrosine (Tyr) 3.46 ± 0.02 a 0.60 ± 0.16 e 0.86 ± 0.07 d 1.02 ± 0.07 d 0.96 ± 0.12 d 1.92 ± 0.30 c 3.22 ± 0.19 a 2.37 ± 0.23 b 
Valine (Val)2 5.49 ± 0.02 a 2.61 ± 0.04 c 2.38 ± 0.01 d 2.77 ± 0.01 c 3.63 ± 0.03 b 3.47 ± 0.07 b 2.87 ± 0.06 c 2.79 ± 0.03 c 
Methionine (Met)2 3.74 ± 0.02 a 2.24 ± 0.04 b 1.75 ± 0.02 b,c 1.97 ± 0.02 b 2.09 ± 0.03 b 2.09 ± 0.07 b 1.58 ± 0.04 c 1.58 ± 0.06 c 
Phenylalanine (Phe)2 4.24 ± 0.01 a 2.41 ± 0.14d,e 2.39 ± 0.06 d,e 2.32 ± 0.05 e 2.62 ± 0.10 d 3.16 ± 0.24 c 3.54 ± 0.17 b 3.17 ± 0.18 c 
 Isoleucine (Ile)2 5.32 ± 0.02 a 2.33 ± 0.04 b 1.50 ± 0.02 c 1.63 ± 0.02 c 2.18 ± 0.02 b 2.42 ± 0.07 b 2.88 ± 0.04 b 2.62 ± 0.03 b 
Leucine (Leu)2 9.21 ± 0.03 a 4.50 ± 0.09 b 3.48 ± 0.03 d 3.91 ± 0.02 c 4.72 ± 0.07 b 4.94 ± 0.15 b 4.09 ± 0.11 c 3.92 ± 0.11 c 
Lysine (Lys)2 13.37 ± 0.05d 16.77 ± 0.11b 13.11 ± 0.05 d 15.64 ± 0.08 c 17.73 ± 0.04 a 15.02 ± 0.18c 11.48 ± 0.07e 11.13 ± 0.14e 
Hydroxyproline 
(Hyp) 
1.61 ± 0.05 e 2.91 ± 0.06 c 4.70 ± 0.03 a 3.49 ± 0.04 b 2.27 ± 0.04 d 1.52 ± 0.10 e 2.20 ± 0.07 d 2.12 ± 0.08 d 
Proline (Pro) 5.08 ± 0.02 b 4.76 ± 0.07 c 6.10 ± 0.04 a 5.12 ± 0.04 b 3.93 ± 0.04 d 3.26 ± 0.12 e 4.10 ± 0.07 d 3.96 ± 0.10 d 
Total 100 100 100 100 100 100 100 100 
 828 
Values are given as mean ± SD from duplicate determinations (n= 2). 829 
a,b,c Different letters in the same line indicate significant differences (p < 0.05). 830 
1 Asx = Asp + Asn; Glx= Glu + Gln. 831 
2 Essential amino acids. 832 
nd: not detected. 833 
 834 
 835 
 836 
 837 
 838 
 839 
 840 
 841 
 842 
 843 
 844 
Table 7 845 
Antibacterial activity of FZPH fractions obtained from size-exclusion chromatography. The 846 
concentration of fractions was 5 mg/ml. 847 
Organism indicator Fractions G25  
F1 F2 F3 F4 F5 F6 
Gram (+)        
S. aureus  − − − − − − 
B. cereus  − − − − − − 
M. luteus  − + − + − − 
Gram (-)        
E. coli  ++ +++ + ++ − − 
P. aeruginosa  − − − − − − 
K. pneumoniae  − +++ ++ ++ − − 
S. enterica  − + − − − − 
S. typhi  − − − − − − 
Enterobacter sp.  − + − − − − 
 848 
 849 
 850 
 851 
 852 
 853 
 854 
 855 
 856 
 857 
 858 
 859 
 860 
 861 
 862 
 863 
 864 
 865 
 866 
 867 
 868 
Table 8 869 
Identification of peptides present in sub-fractions A (a) and B (b) by nano-liquid chromatography and mass spectrometry in tandem.  870 
Sequence Observeda 
(m/z) 
Expectedb 
(Mr) 
 
Charge 
statec (+) 
Calculatedd 
(Mr) 
Modificationse Protein origin 
AGATGGSVP 358.738 715.462 2 715.350 Deamidated(N)@7 REVERSED NAD-dependent L-serine dehydrogenase 
AGCAGVGGAG 360.221 718.427 2 718.307 Oxidation(M)@10 Chemotactic signal transduction system substrate-binding protein BasB 
LSKNLAGA 387.236 772.458 2 772.444  Trace amine-associated receptor 5 
DDFNPSVH 465.705 929.395 2 929.388  Hemoglobin subunit alpha 
GLPPYPYAG 467.743 933.472 2 933.459  Regucalcin 
LVDGLDVGIL 507.278 1012.542 2 1012.580  Very-long-chain 3-oxoacyl-CoA reductase 
LFDKPVSPL 508.295 1014.576 2 1014.575 Oxidation(M)@11 Creatine kinase M-type 
EADDWLRY 534.241 1066.467 2 1066.472  Glycogen phosphorylase, liver form 
TYDDYVEGL 537.739 1073.464 2 1073.455  Myosin light chain 3, skeletal muscle isoform 
VDPENFRLL 551.802 1101.589 2 1101.582  Hemoglobin subunit gamma-1 
LEGDLKLSQE 566.303 1130.592 2 1130.582  Myosin-13  
GVDNPGHPFIM 592.284 1182.554 2 1182.549  Creatine kinase M-type 
LSYEEAITTY 595.356 1188.699 2 1188.555  REVERSED Phosphoenolpyruvate carboxylase 
ALPYDTPVPGY 596.801 1191.587 2 1191.581  Glycogen phosphorylase, liver form 
GYPDKIIIGMD 611.315 1220.616 2 1220.611  Beta-enolase 
ETPGGTPLAPEPD 640.801 1279.587 2 1279.593 Arg-loss@C-term Endoribonuclease YbeY 
HHPDDFNPSVH 434.529 1300.564 3 1300.558 Deamidated(Q)@5; Oxidation(M)@10 Hemoglobin subunit alpha 
LAGNEDVILPVPA 654.384 1306.754 2 1306.713 Oxidation(M)@3 Alpha-enolase 
IDDLEDELYAQ 662.310 1322.606 2 1322.588  Tropomyosin alpha-1 chain 
a 
 871 
 872 
 873 
 874 
 875 
 876 
 877 
 878 
 879 
 880 
 881 
 882 
 883 
 884 
 885 
 886 
 887 
 888 
 889 
 890 
 891 
 892 
 893 
 894 
 895 
a Molecular ion mass observed in the nLC–MS/MS system in mass/charge (m/z). 896 
b Expected molecular mass in Daltons calculated from the observed m/z. 897 
c Charge of the ion as [M+ H]+. 898 
d Calculated relative molecular mass in Daltons. 899 
g Postrasductional modification oxidation of the methionine. 900 
 901 
 902 
 903 
 904 
 905 
 906 
 907 
 908 
 909 
 910 
 911 
 912 
 913 
 914 
 915 
 916 
VIISAPSADAPMF 667.850 1333.685 2 1333.659 Oxidation(M)@12 Glyceraldehyde-3-phosphate dehydrogenase 
FAGDDAPRAVFPS 675.332 1348.650 2 1348.641  Actin-2  
FDMFDTDGGGDIS 688.772 1375.529 2 1375.524  Troponin C, skeletal muscle 
RIEELEEEIEAE 744.861 1487.708 2 1487.699  Myosin-13  
ISWYDNEFGYSN 747.820 1493.6026 2 1493.610  Glyceraldehyde-3-phosphate dehydrogenase  
ISWYDNEFGYSNR 747.818 1493.622 2 1493.610 Arg-loss@C-term Glyceraldehyde-3-phosphate dehydrogenase 
VTWYDNEFGYSNR 747.818 1493.622 2 1493.610 Arg-loss@C-term Glyceraldehyde-3-phosphate dehydrogenase 
VTWYDNEFGYSN 758.809 1515.603 2 1515.592 Cation:Na(E)@7 Glyceraldehyde-3-phosphate dehydrogenase 
LEKSYELPDGQVIT 796.423 1590.832 2 1590.814 Oxidation(M)@7; Oxidation(M)@10 Actin-2  
 917 
Sequence Observeda 
(m/z) 
Expectedb 
(Mr) 
Charge 
statec (+) 
Calculatedd 
(Mr) 
Modificationse Protein origin 
QQEISDLTEQL 643.815 1285.615 2 1285.604 Gln->pyro-Glu@N-term Myosin heavy chain, fast skeletal muscle  
QQEISDLTEQI 643.815 1285.615 2 1285.604 Gln->pyro-Glu@N-term Myosin-2 
TDAETKAFLKAGD 456.236 1365.686 3 1365.677  Parvalbumin beta 1 
ISERLEEAGGATAA 687.865 1373.715 2 1373.679  Myosin heavy chain, fast skeletal muscle 
VEDLMIDVERANS 745.868 1489.721 2 1489.708  Myosin heavy chain, fast skeletal muscle  
NVLSGGTTMYPGIAD  748.367 1494.719 2 1494.702  Actin, alpha skeletal muscle 
AEQELVDASERVGL 758.366 1514.717 2 1514.757  Myosin heavy chain, fast skeletal muscle  
AVPSGASTGVHEALEL 769.405 1536.795 2 1536.778  Enolase 
LTEEMASQDESIAK 776.371 1550.728 2 1550.713  Myosin heavy chain, fast skeletal muscle  
AAVPSGASTGVHEALEL 804.924 1607.833 2 1607.815  Enolase 
WAAFPPDVAGNVDYKN 890.430 1778.847 2 1778.826 Oxidation(W)@1 Myosin regulatory light chain 2, skeletal muscle 
TERAEDEEEINAELTAK 659.344 1975.010 3 1974.902 Formyl@N-term Myosin-2 
GQKDSYVGDEAQSKRGILT 513.763 2051.022 4 2051.028  Actin, alpha skeletal muscle 
LRMDLERAKRKLEGDLK 415.240 2071.165 5 2070.173  Myosin heavy chain, fast skeletal muscle  
NRRIQLVEEELDRAQER 539.292 2153.139 4 2153.130  Tropomyosin alpha-1 chain 
YETDAIQRTEELEEAKKK 546.031 2180.097 4 2180.096  Myosin heavy chain, fast skeletal muscle  
AIQRTEELEEAKKKLAQRL 564.327 2253.278 4 2253.280  Myosin heavy chain, fast skeletal muscle 
TESGEFSRQLDEKEALVSQL 770.374 2308.100 3 2308.118 Carbamyl(R)@8 Myosin-2 
KKKLAQRLQDAEESIEAVNSK 597.083 2384.303 4 2384.302  Myosin heavy chain, fast skeletal muscle  
KMEGDLNEMEIQLSHANRQAA 601.032 2400.098 4 2400.116 Oxidation(M)@9 Myosin heavy chain, fast skeletal muscle  
b 
 918 
 919 
IKVLTDKLKEAETRAEFAERS 812.113 2433.318 3 2433.323  Tropomyosin alpha-1 chain 
DLLIDLANEVKLQEKIDNLING 621.340 2481.333 4 2481.321 Deamidated(N)@8; Deamidated(Q)@13 Glucose-6-phosphate isomerase 
IDNLQRVKQKLEKEKSEYKM 502.281 2506.369 5 2506.357  Myosin heavy chain, fast skeletal muscle  
AAALRKEQADSVAELGEQIDNLQR 875.841 2624.501 3 2624.352  Myosin heavy chain, fast skeletal muscle  
DLQHRLDEAESLAMKGGKKQLQK 663.357 2649.400 4 2649.391 Delta:H(2)C(2)(K)@15; Deamidated(Q)@20 Myosin heavy chain, fast skeletal muscle  
LLREQYEEEQEAKAELQRGMSKA 684.843 2735.343 4 2735.355  Myosin heavy chain, fast skeletal muscle  
MEGDLNEMEIQLSHANRQAAEAQK 687.065 2744.233 4 2744.249 Oxidation(M)@1; Oxidation(M)@8 Myosin heavy chain, fast skeletal muscle  
LTKLEEAEKAADESERGMKVIENR 461.240 2761.397 6 2761.391 Oxidation(M)@18 Tropomyosin alpha-1 chain 
ARLQTENGEFSRQLEEKEALVSQL 926.485 2776.434 3 2776.388 Deamidated(N)@7; Deamidated(Q)@13 Myosin heavy chain, fast skeletal muscle  
LSKEKKALQETHQQTLDDLQAEED 700.103 2796.383 4 2796.377  Myosin-8 
LTVKEDQVFPMNPPKFDKIEDMAM 947.149 2838.424 3 2838.364 Oxidation(M)@11 Myosin-2 
MEGDLNEMEIQLSHANRQAAEAQKQ 715.058 2856.204 4 2856.313 Oxidation(M)@8 715.058 
VQGQLKDTQLHLDDALRGQEDLKEQ 720.123 2876.465 4 2876.463  Myosin-3 
VDDLEGSLEQEKKLRMDLERAKRK 481.931 2885.542 6 2885.539  Myosin heavy chain, fast skeletal muscle  
VLAEWKQKYEESQAELEGAQKEARS 585.694 2923.436 5 2922.436 Oxidation(W)@5 Myosin heavy chain, fast skeletal muscle  
GEQIDNLQRVKQKLEKEKSEYKME 984.195 2949.563 3 2949.523  Myosin heavy chain, fast skeletal muscle  
ALRKEQADSVAELGEQIDNLQRVKQK 593.936 2964.645 5 2965.594  Myosin heavy chain, fast skeletal muscle 
AAALRKEQADSVAELGEQIDNLQRVKQK 777.728 3106.883 4 3107.669  Myosin heavy chain, fast skeletal muscle 
QQVDDLEGSLEQEKKLRMDLERAKRK 524.610 3141.619 6 3141.656  Myosin heavy chain, fast skeletal muscle  
MASQDESIAKLTKEKKALQEAHQQTLDDL 1096.197 3285.569 3 3285.640 Oxidation(H)@22; Deamidated(Q)@24 Myosin heavy chain, fast skeletal muscle  
RARLQTENGEFSRQLEEKEALVSQLTRGKQA 715.803 3573.978 5 3573.850 Deamidated(N)@8; Deamidated(Q)@14 Myosin heavy chain, fast skeletal muscle 
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Table 9 
Peptides identified from F2 in the sub-fractions A (a) and B (b) sharing sequences with 
previously identified bioactive peptides basing on Biopep data bases. 
 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Sequence Previously identified bioactive peptides 
Sequence Activity Reference 
P1 GLPPYPYAG GLP  
GLPQE   
ACE inhibitor 
Antimicrobial 
Byun and Kim [33] 
Hayes et al. [32] 
P2 LVDGLDVGIL FLPLIGRVLSGIL~ ; FLPLIGKVLSGIL~ ; 
FFPVIGRILNGIL~  
Antibacterial Simmaco et al. [34] 
P3 EADDWLRY LRY  ACE inhibitor Meisel et al. [39] 
P4 LEGDLKLSQE LKKLKKLKKKLLKL  
LKL  
Antibacterial 
ACE inhibitor 
Appendini and Hotchkiss [40] 
Ukeda et al. [41] 
P5 LSYEEAITTY KVREGTTY  
 
ACE inhibitor Lee et al. [42] 
P6 ETPGGTPLAPEPD QELLLNPTHQYPVTQPLAPVHNPISV  
QELLLNPTHQIYPVTQPLAPVHNPISV   
Antimicrobial 
Antibacterial 
Hayes et al. [32] 
Minervini et al. [43] 
P7 HHPDDFNPSVH HHP ; HHPL ; HHPLL  Antioxidant Chen et al. [44] 
P8 FAGDDAPRAVFPS VFPS  ACE inhibitor  Loponen [45] 
P9 FDMFDTDGGGDIS NDAACAAHCLFRGRSGGG  Antibacterial Lee et al. [46] 
P10 RIEELEEEIEAE LEELEEELEGCE  Antioxidative Qian et al. [47] 
a 
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 Sequence Similar sequence   
Sequence Activity Reference 
P1 QQEISDLTEQI KTKLTEEEKNRLNFLKKISQRYQKFAL
PQYLKTVYQHQK 
Antibacterial Zucht et al. [48] 
P2 ISERLEEAGGATAA ISELGW  Antioxidative Tsopmo et al. [49] 
P3 NVLSGGTTMYPGIAD  MYPGIA  ACE inhibitor Escudero et al. [50] 
P4 AEQELVDASERVGL VGL  DPP IV inhibitor Nongonierma et al. [51] 
P5 AVPSGASTGVHEALEL AVP ; AVPYP  
AVPYPQR  
AVPYPQR  
ACE inhibitor 
ACE-inhibitor 
Antioxidant 
Meisel, [52] 
Maruyama et al. [53] 
Rival et al. [54] 
P6 LTEEMASQDESIAK IAK  
FSDKIAK  
ACE inhibitor 
ACE inhibitor                               
Antibacterial 
Gomez-Ruiz et al. [55] 
Lopez-Exposito et al. [35] 
Lopez-Exposito et al. [36] 
P7 AAVPSGASTGVHEALEL AAVALLPAVLLALLAPAAANYKKPKL  
VPSGK  
Regulating cell-permeability  
Antioxidative 
Du et al. [56] permeabilit 
Suetsuna, [57] 
P8 WAAFPPDVAGNVDYKN AFPPPNVPGPRFPPPNFPGPRFPPPNFPG
PRFPPPNFPGPRFPPPNFPGPPFPPPIFPGP
WFPPPPPFRPPPFGPPRFP  
Antibacterial Harwig et al. [58] 
 
  QERGSIVIQGTKEGKSRPSLDIDYKQRV
YDKNGMTGDAYGGLNIRPGQPSRQHA
GFEFGKEYKNGFIKGQSEVQRGPGGRL
SPYFGINGGFRF  
Antibacterial 
 
Casteels-Josson et al. [59] 
P9 TERAEDEEEINAELTAK TERGY  Antioxidant Liu et al. [60] 
P10 GQKDSYVGDEAQSKRGILT FLPLIGRVLSGIL~  Antibacterial Simmaco et al. [34] 
P11 LRMDLERAKRKLEGDLK SIQDLKVSMKLFRKQAKWKIIVKLNDG
RELSLD  
Antibacterial Mayo et al. [61] 
P12 NRRIQLVEEELDRAQER GKKIATYQER ; GHKIATFQER  ACE inhibitor Kohama et al. [62] 
P13 YETDAIQRTEELEEAKKK LIRLWSHLIHIWFQNRRLKWKKK  Membrane active Ferrer – Miralles et al. [63] 
P14 AIQRTEELEEAKKKLAQRL KTKLTEEEKNRLNFLKKISQRYQKFAL
PQYLKTVYQHQK 
Antibacterial Zucht et al. [48] 
P15 TESGEFSRQLDEKEALVSQL TESQSLT  
LLGDFFRKSKEKIGKEFKRIVQRIKDFL
RNLVPRTES 
ACE inhibitor 
Antibacterial 
De Gobba et al. [64] 
Larrick et al. [65] 
P16 KMEGDLNEMEIQLSHANRQAA GILDTIKSIASKVWNSKTVQDLKRKGIN
WVANKLGVSPQAA  
Antibacterial Torres-Larios et al. [38] 
P17 IDNLQRVKQKLEKEKSEYKM GLLQTIKEKLESLESLAKGIVSGIQAG  Antibacterial Rozek et al. [66] 
P18 AAALRKEQADSVAELGEQIDNLQR AAATP  
AAATP ; AAAAG   
ACE inhibitor 
DPP IV inhibitor 
Escudero et al. [67] 
Gallego et al. [68] 
P19 LLREQYEEEQEAKAELQRGMSKA LLR  Antioxidant De Gobba et al. [64] 
b 
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P20 LTKLEEAEKAADESERGMKVIENR EQLTK  Antibacterial Pellegrini et al. [69] 
P21 ARLQTENGEFSRQLEEKEALVSQL LARL  Antioxidant  Bougatef et al. [70] 
P22 LSKEKKALQETHQQTLDDLQAEED LSKAQSDFG  Antioxidative Shen et al. [71] 
P23 VLAEWKQKYEESQAELEGAQKEARS ARSYGNGVYCNNKKCWVNRGEATQSI
IGGMISGWASGLAGM  
Antibacterial Tichaczek et al. [72] 
P24 QQVDDLEGSLEQEKKLRMDLERAKRK KKWHKRKK ; KGWHKRKK  Antibacterial Mukhija et al. [73] 
42 
 
Figure captions 
 
Fig. 1. RP-HPLC profiles of zebra blenny meat flour (ZMF) and its hydrolysate (ZPH). The 
column was equilibrated with solvent A (0.1% TFA in ultrapure water) and peptides were 
eluted with a linear increase in solvent B (0.085% TFA in acetonitrile:water (60:40 v:v)) from 
0% to 100%. 
 
Fig. 2. Maldi-Tof spectra of zebra blenny meat flour (ZMF) and its hydrolysate (ZPH), 
meseared from 600 to 2000 Da. 
 
Fig. 3. Elution profile of zebra blenny protein hydrolysate separated by size exclusion 
chromatography on Sephadex G-25. 
 
Fig. 4. Reversed-phase chromatographic separation of ZPH-F2 fraction obtained from size-
exclusion chromatography. Fractions were automatically collected, freeze dried and then 
assayed for antibacterial activity. Fractions eluted from 3 to 6 min and fraction 47 min were 
pooled separately and named sub-fractions A and B, respectively. 
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Fig. 2. 
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Fig. 4. 
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